Merck & Co Inc (NYSE:MRK)

57.60
Delayed Data
As of Mar 26
 -0.66 / -1.13%
Today’s Change
52.49
Today|||52-Week Range
63.62
+1.43%
Year-to-Date
Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog
Mar 26 / Zacks.com
Dow 30 Stock Roundup: Cinderella Stars for Disney, Boeing Wins $713.9M CH-47 Contract...
Mar 20 / Zacks.com
The Downgrades Are Coming
Mar 25 / TheStreet.com
Is Merck & Co., Inc. (MRK) Stock Ready To Resume Uptrend?
Mar 20 / Investing Channel
US consumer stocks rise after Kraft and Heinz deal
Mar 25 / FT.com
Why I'm Not Giving Up on This Tiny Biotech Stock (Yet)
Mar 18 / MotleyFool.com
4 Top-Ranked Health Care ETFs for a Healthy Portfolio - ETF News And Commentary
Mar 25 / Zacks.com
Pharma Stock Outlook: Let's Make a Deal - Industry Outlook
Mar 17 / Zacks.com
Stocks Sell Off on Fed Jitters; Oil Rallies as Yemen Fights Intensify
Mar 25 / TheStreet.com
Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews
Mar 17 / Zacks.com
Jim Cramer Sees American Express Unable to Challenge Visa, MasterCard
Mar 25 / TheStreet.com
Merck Reports Encouraging Data from Cardiovascular Study - Analyst Blog
Mar 17 / Zacks.com
Merck (MRK) Stock Gains Today on Share Repurchase
Mar 25 / TheStreet.com
Stock Market News for March 17, 2015 - Market News
Mar 17 / Zacks.com
Stocks Fall on Uncertainty Over Slide in Durable Goods
Mar 25 / TheStreet.com
Merck's Sugammadex Faces Setback, FDA Delays Meeting - Analyst Blog
Mar 16 / Zacks.com
Stock Futures Are Mixed; Kraft Surges on Heinz Merger News
Mar 25 / TheStreet.com
The $136 Billion Cost of Hepatitis C Treatment
Mar 16 / MotleyFool.com
Merck (MRK) Stock Gains Today on Positive Phase III Melanoma Treatment Study Results
Mar 24 / TheStreet.com
Why Advaxis, Inc. Stock Ripped Higher Today
Mar 16 / MotleyFool.com
Merck (MRK) Strong In Pre-Market Trading
Mar 24 / TheStreet.com
Centerview builds record on pharma deals
Mar 05 / FT.com
11 Promising New Drugs Expected to Make Billions in Sales
Mar 23 / TheStreet.com
Q&A - why Abbvie had to strike $21bn Pharmacyclics deal
Mar 05 / FT.com
3 Things You Need to Know About Achillion Pharmaceuticals Inc.
Mar 22 / MotleyFool.com
Merck predicts flat earnings for 2015
Mar 03 / FT.com
Why Pfizer Inc. Isn't Built to Last
Mar 21 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account